Literature DB >> 9918892

Sustained elevation of plasma brain natriuretic peptide levels associated with progressive ventricular remodelling after acute myocardial infarction.

N Nagaya1, Y Goto, T Nishikimi, M Uematsu, Y Miyao, Y Kobayashi, S Miyazaki, S Hamada, S Kuribayashi, M Takamiya, H Matsuo, K Kangawa, H Nonogi.   

Abstract

Previous studies have shown that levels of plasma brain natriuretic peptide (BNP) increase in an early phase of acute myocardial infarction. However, the relations between plasma BNP levels and left ventricular remodelling, which occurs long after acute myocardial infarction, are not fully understood. Venous plasma BNP levels were measured 2, 7, 14, 30, 90 and 180 days after the onset of acute myocardial infarction in 21 patients. Left ventricular end-diastolic volume index (EDVI, ml/m2) in acute (5 days) and chronic (6 months) phases were assessed by electron-beam computed tomography using Simpson's method. The remodelling group (n=9) was defined by an increase in EDVI >/=5 ml/m2 relative to the baseline value. Plasma BNP levels on days 2, 7, 14, 30 and 90 were significantly higher in the remodelling group than in the non-remodelling group (n=12, P<0.05). Sustained elevation of plasma BNP levels was noted from day 2 (61+/-12 pmol/l) to day 90 (55+/-12 pmol/l) and significantly decreased on day 180 (24+/-3 pmol/l) in the remodelling group. In contrast, plasma BNP levels significantly decreased from day 2 (25+/-4 pmol/l) to day 90 (9+/-1 pmol/l) and reached a steady level thereafter in the non-remodelling group. Plasma BNP levels on day 7 correlated positively with an increase in EDVI (r=0.70, P<0.001) from the acute to chronic phase. More importantly, the sustained elevation of plasma BNP (percentage decrease smaller than 25%) from day 30 to day 90 identified patients in the remodelling group with a sensitivity of 100% and a specificity of 83%. In conclusion, not only the high levels of plasma BNP in an acute phase, but also the sustained elevation of plasma BNP in a chronic phase, may be associated with progressive ventricular remodelling occurring long after acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918892

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

1.  Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction.

Authors:  J G Crilley; M Farrer
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

2.  Cardiac fibrosis in mice lacking brain natriuretic peptide.

Authors:  N Tamura; Y Ogawa; H Chusho; K Nakamura; K Nakao; M Suda; M Kasahara; R Hashimoto; G Katsuura; M Mukoyama; H Itoh; Y Saito; I Tanaka; H Otani; M Katsuki
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

3.  Post-myocardial infarction intraventricular conduction defects and B-type natriuretic peptide levels.

Authors:  Katarzyna Ciuraszkiewicz; Marianna Janion; Janusz Sielski; Dariusz Dudek; Zenon Gawor
Journal:  Clin Cardiol       Date:  2009-06       Impact factor: 2.882

4.  B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study.

Authors:  Kirsten Bibbins-Domingo; Maria Ansari; Nelson B Schiller; Barry Massie; Mary A Whooley
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

5.  NT-proBNP Level Predicts Extent of Myonecrosis and Clinical Adverse Outcomes in Patients with ST-Elevation Myocardial Infarction: A Pilot Study.

Authors:  Mohammad Mathbout; Ahmed Asfour; Steve Leung; Georges Lolay; Amr Idris; Ahmed Abdel-Latif; Khaled M Ziada
Journal:  Med Res Arch       Date:  2020-02-21

6.  Physiology and clinical significance of natriuretic hormones.

Authors:  Sandeep Chopra; Davis Cherian; Prashant Paul Verghese; Jubbin J Jacob
Journal:  Indian J Endocrinol Metab       Date:  2013-01

Review 7.  Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure.

Authors:  Shihui Fu; Ping Ping; Fengqi Wang; Leiming Luo
Journal:  J Biol Eng       Date:  2018-01-12       Impact factor: 4.355

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.